Whitney W. Stevens
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Whitney W. Stevens has a total of 130 co-authors. Here are the top co-authors by number of shared publications:
- Bruce K. Tan
Department of Otolaryngology Northwestern University Feinberg School of Medicine Chicago Illinois USA
12 shared publications Anju T. Peters
Division of Allergy and Immunology, Northwestern University Feinberg School of Medicine, Chicago, Ill
11 shared publications- Anju Tripathi Peters
Division of Allergy and Immunology Feinberg School of Medicine Northwestern University Chicago Illinois USA
10 shared publications - Atsushi Kato
Division of Allergy and Immunology, Department of Medicine Northwestern University Feinberg School of Medicine Chicago Illinois USA
10 shared publications - Stephanie Shintani Smith
Department of Otolaryngology Northwestern University Feinberg School of Medicine Chicago Illinois USA
10 shared publications Robert C. Kern
Division of Allergy and Immunology Department of Medicine Northwestern University Feinberg School of Medicine Chicago Illinois USA
9 shared publications
Latest Publications
- 21 September 2026
- Published by Elsevier in Journal of Allergy and Clinical Immunology
Mechanistic and clinical updates in chronic rhinosinusitis: 2023 to 2025
- 21 September 2026
- Published by Elsevier in Journal of Allergy and Clinical Immunology
Mechanistic and clinical updates in chronic rhinosinusitis: 2023 to 2025
- 19 December 2025
- Published by Elsevier in The Journal of Allergy and Clinical Immunology: In Practice
- Vol. 14 (2) , 385-394
Overview of Biologics Targeting Type 2 Inflammation in Respiratory Disease
- 19 December 2025
- Published by Elsevier in The Journal of Allergy and Clinical Immunology: In Practice
- Vol. 14 (2) , 385-394
Overview of Biologics Targeting Type 2 Inflammation in Respiratory Disease
- 28 November 2025
- Published by Wiley in International Forum of Allergy & Rhinology
- Vol. 16 (4) , 345-352
The Association Between Sinus Surgery and the Development of Asthma and Non‐Cystic Fibrosis Bronchiectasis in Patients With Chronic Rhinosinusitis
Background: Precedent chronic rhinosinusitis (CRS) is associated with new‐onset asthma and non‐cystic fibrosis bronchiectasis (BE). Objective: To assess if endoscopic sinus surgery (ESS) mitigates the development of lower airway diseases in patients with CRS. Methods: This retrospective study utilized electronic medical records from an academic center. CRS patients ( > 18 years old) without asthma or BE, were identified between January 2006 and December 2013. Charts were reviewed until May 2023. New diagnoses of asthma or BE were identified in patient records following ESS before December 2018 compared to patients without ESS. Lund–Mackay (LM) scores were calculated in a random subset of patients to assess disease severity. Logistic regression was used to estimate the odds of developing asthma or BE by ESS status. Results: A total of 1877 patients underwent ESS, while 13,453 did not. CRS severity was higher in the ESS group (LM, 9.02) versus no ESS group (LM, 4.28). After up to 17 years of follow‐up, 207/1877 (11%) and 40/1877 (2.1%) of patients with ESS had a new asthma or BE diagnosis, respectively. Out of 13,453 patients, 1778 (13.2%) and 293 (2.2%) patients without ESS had a new asthma or BE diagnosis. The unadjusted odds of a new asthma diagnosis were lower by 19% for ESS versus no ESS; OR (95% CI), 0.81 (0.70–0.95). After controlling for confounders (age, gender, race/ethnicity, smoking status, and chronic rhinitis), the association remained significant, with a 15% reduction in the odds of a new asthma diagnosis; OR (95% CI), 0.85 (0.73–0.99). There was no association between ESS status and a new diagnosis of BE. Conclusions: Despite higher CRS severity, patients undergoing ESS had a lower risk of a new asthma diagnosis and did not have a higher risk of developing BE.
- 28 November 2025
- Published by Wiley in International Forum of Allergy & Rhinology
- Vol. 16 (4) , 345-352
The Association Between Sinus Surgery and the Development of Asthma and Non‐Cystic Fibrosis Bronchiectasis in Patients With Chronic Rhinosinusitis
Background: Precedent chronic rhinosinusitis (CRS) is associated with new‐onset asthma and non‐cystic fibrosis bronchiectasis (BE). Objective: To assess if endoscopic sinus surgery (ESS) mitigates the development of lower airway diseases in patients with CRS. Methods: This retrospective study utilized electronic medical records from an academic center. CRS patients ( > 18 years old) without asthma or BE, were identified between January 2006 and December 2013. Charts were reviewed until May 2023. New diagnoses of asthma or BE were identified in patient records following ESS before December 2018 compared to patients without ESS. Lund–Mackay (LM) scores were calculated in a random subset of patients to assess disease severity. Logistic regression was used to estimate the odds of developing asthma or BE by ESS status. Results: A total of 1877 patients underwent ESS, while 13,453 did not. CRS severity was higher in the ESS group (LM, 9.02) versus no ESS group (LM, 4.28). After up to 17 years of follow‐up, 207/1877 (11%) and 40/1877 (2.1%) of patients with ESS had a new asthma or BE diagnosis, respectively. Out of 13,453 patients, 1778 (13.2%) and 293 (2.2%) patients without ESS had a new asthma or BE diagnosis. The unadjusted odds of a new asthma diagnosis were lower by 19% for ESS versus no ESS; OR (95% CI), 0.81 (0.70–0.95). After controlling for confounders (age, gender, race/ethnicity, smoking status, and chronic rhinitis), the association remained significant, with a 15% reduction in the odds of a new asthma diagnosis; OR (95% CI), 0.85 (0.73–0.99). There was no association between ESS status and a new diagnosis of BE. Conclusions: Despite higher CRS severity, patients undergoing ESS had a lower risk of a new asthma diagnosis and did not have a higher risk of developing BE.
- Open Access
- 26 September 2025
- Published by Wiley in International Forum of Allergy & Rhinology
- Vol. 16 (1) , 32-42
Factor Analysis‐Based Quantitative Endotyping Improves Associations With CRS Cross‐Sectional and Longitudinal Outcomes
Background: Chronic rhinosinusitis (CRS) is a heterogeneous inflammatory disease characterized by persistent sinonasal inflammation. There is increasing interest in endotype‐based classification, which categorizes CRS based on underlying inflammatory pathways. We applied factor analysis to facilitate continuous endotype assignment to CRS patients and assess cross‐sectional and longitudinal CRS outcomes. Methods: We prospectively enrolled 203 patients (52 controls, 88 CRSsNP, and 63 CRSwNP) undergoing endoscopic nasal or sinus surgery (ESS). Middle meatal mucus biomarkers were analyzed pre‐ESS (V0) and 6–12 months post‐ESS (V1). Factor analysis was performed to identify latent factors. Factor scores were generated, and statistical analyses were conducted to assess correlations with radiographic (Lund–Mackay [LM]) and patient‐reported (SNOT‐22, CRS‐PRO) outcomes measured at V0, V1, and V2 (1.5–5 years post‐ESS). Results: Four factors were identified: Type 1 (T1), Type 2 (T2), Type 3 (T3), and macrophage‐associated (M). CRSwNP patients had higher T2 and M factor scores than CRSsNP and controls. T2, T3, and M factor scores demonstrated stronger or equivalent associations with radiographic and patient‐reported outcomes compared to individual biomarkers. Following ESS, median T2 and M factor scores significantly declined, while T1 and T3 remained stable. V0 T1 and T2 were weakly associated with long‐term (V2) radiographic and symptom scores. V1 factor scores were more consistently predictive of long‐term (V2) outcomes, with T2, T3, and M demonstrating modest correlations with radiographic severity and CRS‐PRO. Conclusions: Factor analysis identifies distinct, quantifiable patterns of inflammation in CRS, offering improved associations with cross‐sectional and longitudinal outcomes compared to individual biomarkers.
- 26 September 2025
- Published by Wiley in International Forum of Allergy & Rhinology
- Vol. 16 (1) , 32-42
Open AccessFactor Analysis‐Based Quantitative Endotyping Improves Associations With CRS Cross‐Sectional and Longitudinal Outcomes
Background: Chronic rhinosinusitis (CRS) is a heterogeneous inflammatory disease characterized by persistent sinonasal inflammation. There is increasing interest in endotype‐based classification, which categorizes CRS based on underlying inflammatory pathways. We applied factor analysis to facilitate continuous endotype assignment to CRS patients and assess cross‐sectional and longitudinal CRS outcomes. Methods: We prospectively enrolled 203 patients (52 controls, 88 CRSsNP, and 63 CRSwNP) undergoing endoscopic nasal or sinus surgery (ESS). Middle meatal mucus biomarkers were analyzed pre‐ESS (V0) and 6–12 months post‐ESS (V1). Factor analysis was performed to identify latent factors. Factor scores were generated, and statistical analyses were conducted to assess correlations with radiographic (Lund–Mackay [LM]) and patient‐reported (SNOT‐22, CRS‐PRO) outcomes measured at V0, V1, and V2 (1.5–5 years post‐ESS). Results: Four factors were identified: Type 1 (T1), Type 2 (T2), Type 3 (T3), and macrophage‐associated (M). CRSwNP patients had higher T2 and M factor scores than CRSsNP and controls. T2, T3, and M factor scores demonstrated stronger or equivalent associations with radiographic and patient‐reported outcomes compared to individual biomarkers. Following ESS, median T2 and M factor scores significantly declined, while T1 and T3 remained stable. V0 T1 and T2 were weakly associated with long‐term (V2) radiographic and symptom scores. V1 factor scores were more consistently predictive of long‐term (V2) outcomes, with T2, T3, and M demonstrating modest correlations with radiographic severity and CRS‐PRO. Conclusions: Factor analysis identifies distinct, quantifiable patterns of inflammation in CRS, offering improved associations with cross‐sectional and longitudinal outcomes compared to individual biomarkers.
- 18 March 2025
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 155 (5) , 1411-1419
Clinical and mechanistic advancements in aspirin exacerbated respiratory disease
- 18 March 2025
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 155 (5) , 1411-1419
Clinical and mechanistic advancements in aspirin exacerbated respiratory disease
- 6 November 2024
- Published by Elsevier in The Journal of Allergy and Clinical Immunology: In Practice
- Vol. 12 (11) , 2945-2946
NSAID-Exacerbated Respiratory Disease—A Century of Discovery and Innovation
- 6 November 2024
- Published by Elsevier in The Journal of Allergy and Clinical Immunology: In Practice
- Vol. 12 (11) , 2945-2946
NSAID-Exacerbated Respiratory Disease—A Century of Discovery and Innovation
- Open Access
- 10 September 2024
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 9 (17)
Increased autoreactivity and maturity of EBI2+ antibody-secreting cells from nasal polyps
Elevated numbers of antibody-secreting cells (ASCs) and anti–double-stranded DNA (anti-dsDNA) antibodies are found in nasal polyp (NP) tissue. The presence of anti-dsDNA IgG in tissue prospectively predicts recurrent NP but the characteristics of the source ASCs are unknown. Here, we investigated whether NP B cells expressing the extrafollicular marker EBI2 have increased propensity for autoantibody production and evaluated the molecular characteristics of NP ASCs. NPs showed increased frequencies of anti-dsDNA IgG and total IgG ASCs compared with tonsils, with more pronounced differences among EBI2 + cells. In NPs, EBI2 + cells were frequently double negative (IgD – CD27 – ) and ASCs. Single-cell RNA-Seq analysis of tonsils and NPs revealed substantial differences in B lineage composition, including differences in percentages of ASCs, germinal centers, proliferative cells, and non-ASCs. NPs exhibited higher expression of specific isotypes ( IGHE , IGHA1 , IGHA2 , and IGHG4 ) and mature plasma genes, including SDC1 and XBP1 , than tonsils. Gene Ontology biological processes indicated upregulated NF-κB and downregulated apoptosis pathways in NP ASCs. Together, these data indicate that NP EBI2 + ASCs secret increased total and anti-dsDNA IgG compared with those from tonsils and had molecular features of mature plasma cell differentiation.
- 10 September 2024
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 9 (17)
Open AccessIncreased autoreactivity and maturity of EBI2+ antibody-secreting cells from nasal polyps
Elevated numbers of antibody-secreting cells (ASCs) and anti–double-stranded DNA (anti-dsDNA) antibodies are found in nasal polyp (NP) tissue. The presence of anti-dsDNA IgG in tissue prospectively predicts recurrent NP but the characteristics of the source ASCs are unknown. Here, we investigated whether NP B cells expressing the extrafollicular marker EBI2 have increased propensity for autoantibody production and evaluated the molecular characteristics of NP ASCs. NPs showed increased frequencies of anti-dsDNA IgG and total IgG ASCs compared with tonsils, with more pronounced differences among EBI2 + cells. In NPs, EBI2 + cells were frequently double negative (IgD – CD27 – ) and ASCs. Single-cell RNA-Seq analysis of tonsils and NPs revealed substantial differences in B lineage composition, including differences in percentages of ASCs, germinal centers, proliferative cells, and non-ASCs. NPs exhibited higher expression of specific isotypes ( IGHE , IGHA1 , IGHA2 , and IGHG4 ) and mature plasma genes, including SDC1 and XBP1 , than tonsils. Gene Ontology biological processes indicated upregulated NF-κB and downregulated apoptosis pathways in NP ASCs. Together, these data indicate that NP EBI2 + ASCs secret increased total and anti-dsDNA IgG compared with those from tonsils and had molecular features of mature plasma cell differentiation.
- 30 July 2024
- Published by Elsevier in The Journal of Allergy and Clinical Immunology: In Practice
- Vol. 12 (11) , 2898-2905
Consultation for Chronic Rhinosinusitis With Nasal Polyps and Asthma: Clinical Presentation, Diagnostic Workup, and Treatment Options
- 30 July 2024
- Published by Elsevier in The Journal of Allergy and Clinical Immunology: In Practice
- Vol. 12 (11) , 2898-2905
Consultation for Chronic Rhinosinusitis With Nasal Polyps and Asthma: Clinical Presentation, Diagnostic Workup, and Treatment Options
- Top Cited Papers
- 24 May 2024
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 154 (4) , 952-964
Single cell RNA sequencing of human eosinophils from nasal polyps reveals eosinophil heterogeneity in chronic rhinosinusitis tissue
- 24 May 2024
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 154 (4) , 952-964
Top Cited PapersSingle cell RNA sequencing of human eosinophils from nasal polyps reveals eosinophil heterogeneity in chronic rhinosinusitis tissue
- 21 March 2024
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 154 (1) , 222-228.e4
Prevention of allergic reactions during oxaliplatin desensitization through inhibition of Bruton tyrosine kinase
- 21 March 2024
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 154 (1) , 222-228.e4
Prevention of allergic reactions during oxaliplatin desensitization through inhibition of Bruton tyrosine kinase